Dr Lim Seng Han was a National University of Singapore (NUS) President Graduate Fellowship PhD scholar at the Department of Pharmacy, NUS. His research focused on 3D printing in the field of personalised pharmaceutical dosage forms and drug delivery. Co-founder, Dr Goh Wei Jiang, was a National University of Singapore (NUS) Graduate School of Integrative Sciences & Engineering (NGS) PhD-MBA scholar. After graduating from NUS Pharmacy in 2012, Dr Goh was then awarded the PhD-MBA double degree scholarship where he uncovered his passion for the convergence between technology and commercialisation.
Pharmacists by training, Dr Lim and Dr Goh identified a problem where patients at hospitals brought home bags of medicines with often complicated medication regimes. During their penultimate year of graduate studies, they came up with 3D printing as a solution to manage their daily medicines  Â̶̶ and Craft Health was born.
As first-time founders, Dr Lim and Dr Goh faced many challenges ranging from funding to adaptation of their business model. Thankfully, NUS Enterprise and GRIP have provided access to grants such as the Startup SG Founder grant, while also introducing potential investors and partners to them. Being incubated in the start-up space has also allowed Craft Health to exchange ideas with other start-ups while staying informed of the latest news in the industry. Craft Health is also under the NUS ToughLove programme, granting them access to the Minimum Viable Product (MVP) Studio where they have received invaluable engineering help from Master Engineer Richard Chee.
In less than two years, Craft Health has already chalked up an impressive list of accolades:
Currently, Craft Health is looking at partnering with supplement companies to distribute their nutraceutical products to customers. As for their pharmaceutical products, they are looking to partner/co-develop/license their technology to pharmaceutical companies who are looking to extend patent lifespans through re-formulation exercises, combining multiple proprietary medicines in a single pill, or quick formulation prototyping such as in clinical trials.
In 2021, Craft Health plans to move to a new facility with an office space, laboratory and production lab in order to start their pilot production runs. They aim to complete 2-3 pilot studies with various stakeholders from the academic, hospital, supplement and pharmaceutical companies before scaling up. Moving forward, they will continue to build up their production line and perform various testing and validation of their product and production process.
Craft Health is currently incubated at the NUS Enterprise @Singapore Science Park facility.
To find out more about Craft Health, visit https://www.crafthealth.me/ or their LinkedIn page at https://www.linkedin.com/company/craft-health/.